NCT06095492View on ClinicalTrials.gov

Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Kidney Transplant; ComplicationsDiabetes Mellitus
Interventions
DRUG

Empagliflozin 25 MG

Patient will get Empagliflozin 25

DRUG

Linagliptin

linagliptin 5 mg once a day

Trial Locations (1)

122001

RECRUITING

Division Of Endocrinology & Diabetes, Medanta The Medicity, Gurgaon

All Listed Sponsors
lead

Medanta, The Medicity, India

OTHER